Loading clinical trials...
Loading clinical trials...
Microbial and Human Determinants of the Onset of IBD Flares
This study will collect longitudinal biological samples and survey data to identify the triggers of IBD flares.
This is a longitudinal observational study whose goals are to identify: Microbial and human molecular triggers of IBD relapses, Microbial and human molecular pathways strongly associated with flares that could be targeted with nutrition with a therapeutic potential, Biomarkers of IBD for Dx purposes, Identify microbial functions associated with release of BH4.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
LABOX, Department of Biochemistry, Universidade Federal de Santa Catarina
Florianópolis, Santa Catarina, Brazil
Start Date
January 31, 2025
Primary Completion Date
February 1, 2030
Completion Date
February 1, 2030
Last Updated
June 15, 2025
100
ESTIMATED participants
Lead Sponsor
Viome
Collaborators
NCT07089420
NCT07373457
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions